Physician profile
Rachel E Mock
NPI 1578848446
$655.14
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $266 · 2022: $372 · 2023: $16.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $122.82 | 2021-2022 | |
| Glaxosmithkline, LLC. | $103.47 | 2021-2022 | |
| Novo Nordisk INC | $72.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $71.61 | 2021-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Abbvie INC. | $42.06 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $39.79 | 2022 | |
| Sanofi-Aventis U.S. LLC | $33.36 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.04 | 2021-2022 | |
| Amgen INC. | $30.68 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $20.96 | 2021 | |
| Abbott Laboratories | $20.30 | 2022 | |
| Sanofi Pasteur INC. | $18.00 | 2022 | |
| Amarin Pharma, INC. | $17.83 | 2021 | |
| Medtronic, INC. | $14.85 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Mock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.